期刊文献+

siRNA下调Notch3表达对非小细胞肺癌骨转移能力的影响 被引量:7

The effect of downregulation Notch3 by siRNA on bone metastasis in non small cell lung cancer
下载PDF
导出
摘要 目的:研究Notch3在肺癌骨转移中的作用。方法:通过RT-PCR方法检测Notch3在NSCLC及其伴骨转移患者的肺癌组织中的表达情况;利用慢病毒包装Notch3 siRNA载体抑制Notch3的表达后,通过体外迁移和侵袭试验观察Notch3 siRNA对肺癌细胞的迁移和侵袭能力的影响;通过体外ELISA法检测骨转移相关分子pTHrP和IL-6的表达,研究阻断Notch3的表达后是否能够逆转TGF-β诱导的肺癌骨转移。结果:Notch3在NSCLC发生骨转移的患者肺癌组织中过表达。体外试验发现,通过慢病毒包装Notch3 siRNA载体抑制Notch3的表达后,NSCLC细胞的转移能力下降,且Notch3-si可明显抑制NSCLC细胞中由TGF-β介导的pTHrP和IL-6的表达。结论:Notch3高表达在促进NSCLC骨转移中发挥重要作用。 Objective:To expolre the role of Notch3 in bone metastasis in NSCLC.Methods:RT-PCR assay was used to detect the mRNA level of Notch3 in NSCLC with or without bone metastasis.Lentivirus package siRNA targeting Notch3 was transfected into NSCLC cell lines.Wouding healing assay and Transwell invasive assay were used to observe the effect of Notch3 in metastasis ability in vitro.ELISA assay was used to detect the bone metastasis relative molecular pTHrP and IL-6 expression.Results:Notch3 was overexpressed in NSCLC bone metastasis tissues.Inhibition of Notch3 by siRNA transfection could decrease the invasion ability of NSCLC cells and TGF-induced IL-6 and pTHrP expressionin vitro.Conclusion:The results demonstrated that Notch3 play an important role of bone metastasis in NSCLC.
出处 《现代肿瘤医学》 CAS 2014年第11期2534-2538,共5页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81101765 81172011)
关键词 NOTCH3 TGF-Β 骨转移 非小细胞肺癌 Notch3 TGF-β bone metastasis NSCLC
  • 相关文献

参考文献17

  • 1Lnis C, Hong E J, Pease S,et ah Germline transmission and tissue - specific expression of transgenes delivered by lentiviral vectors[ J]. Science,2002,295 (5556) :868 - 872.
  • 2Wang F, Reierstad S, Fishman DA. Matrilysin over- expression in MCF- 7 cells enhances cellular invasiveness and pro - gelatinase activation [ J ]. Cancer Lett, 2006,236 ( 2 ) : 292 - 301.
  • 3Wright LE, Frye JB, Lukefahr AL, et ah Cureuminoids block TGF - beta signaling in human breast cancer cells and limit osteolysis in a routine model of breast eancer bone metastasis [ J ]. J Nat Prod, 2013,76:316 -321.
  • 4Papaehristou D J, Basdra EK, Papavassiliou AG. Bone metastases: molecular mechanisms and novel therapeutic interventions[ J]. Med Res Rev ,2012,32:611 -636.
  • 5Guelcher SA, Sterling JA. Contribution of bone tissue modulus to blast cancer metastasis to bone [ J ]. Cancer Mieroenviron,2011,4: 247 - 259.
  • 6Mundy GR. Metastasis to bone : causes,consequences and therapeu- tic opportunities[ J ]. Nat Rev Cancer,2002,2:584 - 593.
  • 7Sriuranpong V, Borges MW, Ravi RK,et ah Notch signaling imtuces cell cycle arrest in sin',all cell lung cancer cells [ J ]. Cancer Res, 2001,61 (7) :3200 -3205.
  • 8Nicolas M,Wolfer A,Raj K,et ah Notehl functions as a tumor sup- pressor in mouse skin[J]. Nat Genet,2003,33(3) :416 -421.
  • 9Dotto GP. Notch tumor suppressor function[ J]. Oncogene,2008,27 (38) :5115 -5123.
  • 10Dang TP, Gazdar AF, Virmani AK, et al. Chromosome 19 translo- eation,overexpression of Notch3, and human lung cancer[ J]. J Natl Cancer lnst,2000,92(16) :1355 -1357.

同被引文献78

  • 1吴翠翠,张雪琦,马宏超.老年肺癌患者血清P53抗体、VEGF、TGF-β1水平[J].中国老年学杂志,2014,34(12):3283-3285. 被引量:3
  • 2郑英娟,汤建华,张志林,张志华,张秀珑,冯平.肺癌中SPARC和TGFβ1的表达及意义[J].肿瘤防治研究,2014,41(6):593-597. 被引量:5
  • 3马进元,于鹏,祝毓琳,朱步东.晚期或转移性非小细胞肺癌全身治疗进展[J].中国实用内科杂志,2013,33(S1):164-166. 被引量:18
  • 4Mukherjee S,Kim J,Mooren OL,et al.Role of cortactin homolog HS1 in transendothelial migration of natural killer ce lls[J].PLoS One,2015;10(2):e0118153.
  • 5Shen HL,Liu QJ,Yang PQ,et al.Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma[J].Tumour Biol,2015;36(5):3417-22.
  • 6Labrador-Horrillo M,Martínez MA,Selva-O'Callaghan A,et al.Identification of a novel myositis-associated antibody directed against cortactin[J].Autoimmun Rev,2014;13(10):1008-12.
  • 7Torre LA, Bray F, Siegel RL,et al. Global cancerstatistics, 2012 [J].CA Cancer J Clin,2015 ,65 (2) :87 - 108.
  • 8Mueller S, Phillips J, Onar - Thomas A, et al. PTEN promoter meth- ylation and activation of the PI3K/Akt/mT0R pathway in pediatric gliomas and influence on clinical outcome[ J]. Neuro Oncol,2012, 14(9) :1146 -1152.
  • 9Lee EJ, Kim N, Kang KH, et al. Phosphorylation/inactivation of PTEN by Akt - independent PDK signaling in retinal pigment epi- thelium[J]. Bioch Biophy Res Commun, 2011,414 ( 2 ) :384 - 389.
  • 10Camera A, Blanco - Aparicio C, Renner 0, et al. The PTEN/ PDK/AKT signaling pathway in cancer, therapeutic implications [J]. Curr Cancer Drug Targets,2008,8(3) : 187 - 198.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部